AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy
Authors: Liu, KZ Jia, L Kelsey, SM Newland, AC Mantsch, HH
Citation: Kz. Liu et al., Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy, APOPTOSIS, 6(4), 2001, pp. 269-278
Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma
Authors: McBride, NC Cavenagh, JD Ward, MC Grant, I Schey, S Gray, A Hughes, A Mills, MJ Cervi, P Newland, AC Kelsey, SM
Citation: Nc. Mcbride et al., Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma, LEUK LYMPH, 42(1-2), 2001, pp. 89-98
Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis
Authors: Jia, L Patwari, Y Srinivasula, SM Newland, AC Fernandes-Alnemri, T Alnemri, ES Kelsey, SM
Citation: L. Jia et al., Bax translocation is crucial for the sensitivity of leukaemic cells to etoposide-induced apoptosis, ONCOGENE, 20(35), 2001, pp. 4817-4826
8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNF alpha-induced apoptosis is via inactivation of NF-kappa B
Authors: Yin, YZ Allen, PD Jia, L Kelsey, SM Newland, AC
Citation: Yz. Yin et al., 8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNF alpha-induced apoptosis is via inactivation of NF-kappa B, LEUK RES, 25(5), 2001, pp. 423-431
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells
Authors: Jia, L Srinivasula, SM Liu, FT Newland, AC Fernandes-Alnemri, T Alnemri, ES Kelsey, SM
Citation: L. Jia et al., Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells, BLOOD, 98(2), 2001, pp. 414-421
c-IAP1 blocks TNF alpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells
Authors: Partheniou, F Kelsey, SM Srinivasula, SM Newland, AC Alnemri, ES Jia, L
Citation: F. Partheniou et al., c-IAP1 blocks TNF alpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells, BIOC BIOP R, 287(1), 2001, pp. 181-189
TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax
Authors: Jia, L Patwari, Y Kelsey, SM Newland, AC
Citation: L. Jia et al., TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax, BIOC BIOP R, 283(5), 2001, pp. 1037-1045
Apaf-1XL is an inactive isoform compared with Apaf-1L
Authors: Fu, WN Kelsey, SM Newland, AC Jia, L
Citation: Wn. Fu et al., Apaf-1XL is an inactive isoform compared with Apaf-1L, BIOC BIOP R, 282(1), 2001, pp. 268-272
Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide
Authors: Jenner, MJ Micallef, INM Rohatiner, AZ Kelsey, SM Newland, AC Cavenagh, JD
Citation: Mj. Jenner et al., Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide, MED ONCOL, 17(4), 2000, pp. 333-336
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma
Authors: Shamash, J Walewski, J Apostolidis, J Wilson, AM Foran, JM Gupta, RK Rohatiner, AZS Kelsey, SM Lister, TA
Citation: J. Shamash et al., Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma, ANN ONCOL, 11(7), 2000, pp. 857-860
Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints
Authors: Ketley, NJ Allen, PD Kelsey, SM Newland, AC
Citation: Nj. Ketley et al., Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints, LEUKEMIA, 14(4), 2000, pp. 620-628
Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin
Authors: Rhoades, CJ Williams, MA Kelsey, SM Newland, AC
Citation: Cj. Rhoades et al., Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin, BLOOD REV, 14(1), 2000, pp. 14-30
Autologous transplantation with Philadelphia-negative progenitor cells forpatients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon
Authors: McBride, NC Cavenagh, JD Newland, AC Lillington, DM Murrell, C Kelsey, SM
Citation: Nc. Mcbride et al., Autologous transplantation with Philadelphia-negative progenitor cells forpatients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon, BONE MAR TR, 26(11), 2000, pp. 1165-1172
Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets
Authors: Williams, MA Newland, AC Kelsey, SM
Citation: Ma. Williams et al., Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets, LEUK RES, 24(4), 2000, pp. 317-330
Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immunesurveillance
Authors: Wu, YL Jiang, XR Lillington, DM Newland, AC Kelsey, SM
Citation: Yl. Wu et al., Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immunesurveillance, BR J HAEM, 111(3), 2000, pp. 807-816
CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma
Authors: Parameswaran, R Giles, C Boots, M Littlewood, TJ Mills, MJ Kelsey, SM Samson, D
Citation: R. Parameswaran et al., CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma, BR J HAEM, 109(3), 2000, pp. 571-575
Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha
Authors: Yin, YZ Allen, PD Jia, L Macey, MG Kelsey, SM Newland, AC
Citation: Yz. Yin et al., Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha, BR J HAEM, 108(3), 2000, pp. 565-573
Cost effectiveness of amphotericin B plus G-CSF compared with amphotericinB monotherapy - Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK
Authors: Flynn, TN Kelsey, SM Hazel, DL Guest, JF
Citation: Tn. Flynn et al., Cost effectiveness of amphotericin B plus G-CSF compared with amphotericinB monotherapy - Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK, PHARMACOECO, 16(5), 1999, pp. 543-550
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation
Authors: McBride, NC Ward, MC Mills, MJ Eden, AG Hughes, A Cavenagh, JD Lamont, A Newland, AC Kelsey, SM
Citation: Nc. Mcbride et al., Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation, LEUK LYMPH, 35(3-4), 1999, pp. 339-345
The potential for monocyte-mediated immunotherapy during infection and malignancy. Part II: in vivo activation by exogenous cytokines and clinical applications (vol 34, pg 207, 1999)
Authors: Williams, MA Rhoades, CJ Newland, AC Kelsey, SM
Citation: Ma. Williams et al., The potential for monocyte-mediated immunotherapy during infection and malignancy. Part II: in vivo activation by exogenous cytokines and clinical applications (vol 34, pg 207, 1999), LEUK LYMPH, 35(1-2), 1999, pp. NIL_3-NIL_3
The potential for monocyte-mediated immunotherapy during infection and malignancy - Part II: In vivo activation by exogenous cytokines and clinical applications
Authors: Williams, MA Rhoades, CJ Newland, AC Kelsey, SM
Citation: Ma. Williams et al., The potential for monocyte-mediated immunotherapy during infection and malignancy - Part II: In vivo activation by exogenous cytokines and clinical applications, LEUK LYMPH, 34(3-4), 1999, pp. 207-230
The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: Apoptosis induction and cytotoxic mechanisms
Authors: Williams, MA Newland, AC Kelsey, SM
Citation: Ma. Williams et al., The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: Apoptosis induction and cytotoxic mechanisms, LEUK LYMPH, 34(1-2), 1999, pp. 1-23
GM-CSF and stimulation of monocyte/macrophage function in vivo relevance and in vitro observations
Authors: Williams, MA Kelsey, SM Newland, AC
Citation: Ma. Williams et al., GM-CSF and stimulation of monocyte/macrophage function in vivo relevance and in vitro observations, EUR J CANC, 35, 1999, pp. S18-S22
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study
Authors: Kelsey, SM Goldman, JM McCann, S Newland, AC Scarffe, JH Oppenheim, BA Mufti, GJ
Citation: Sm. Kelsey et al., Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study, BONE MAR TR, 23(2), 1999, pp. 163-168
Pgp-positive leukaemic cells have increased mtDNA but no increased rate ofproliferation
Authors: Jia, L Liu, KZ Newland, AC Mantsch, HH Kelsey, SM
Citation: L. Jia et al., Pgp-positive leukaemic cells have increased mtDNA but no increased rate ofproliferation, BR J HAEM, 107(4), 1999, pp. 861-869
Risultati: 1-25 | 26-27